Angiodynamics Ownership

ANGO
 Stock
  

USD 13.30  0.39  2.85%   

Some institutional investors establish a significant position in stocks such as Angiodynamics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Angiodynamics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits. Please continue to Trending Equities.
  
Angiodynamics Total Assets Per Share are quite stable at the moment as compared to the past year. The company's current value of Total Assets Per Share is estimated at 18.43. Quick Ratio is expected to rise to 1.02 this year, although the value of Interest Coverage will most likely fall to 2.76.
Angiodynamics retains a total of 38.65 Million outstanding shares. The majority of Angiodynamics outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Angiodynamics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Angiodynamics. Please pay attention to any change in the institutional holdings of Angiodynamics as this could imply that something significant has changed or about to change at the company. Also note that nearly seven hundred seventy-three thousand invesors are currently shorting Angiodynamics expressing very little confidence in its future performance.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

Angiodynamics Stock Ownership Analysis

About 97.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.15. Some equities with similar Price to Book (P/B) outperform the market in the long run. Angiodynamics recorded a loss per share of 4.43. The entity had not issued any dividends in recent years. AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access and for use in oncology and surgical settings in the United States and internationally. The company was founded in 1988 and is headquartered in Latham, New York. Angiodynamics operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 760 people. For more info on Angiodynamics please contact Joseph DeVivo at 518 795-1400 or go to www.angiodynamics.com.

Angiodynamics SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Angiodynamics prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Angiodynamics investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Angiodynamics specific information freely available to individual and institutional investors to make a timely investment decision.
31st of August 2022
Financial Statements and Exhibits. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. Termination of a Material Definitive Agreement. Entry into a Material Definitive Agreement
View
9th of February 2022
Unclassified Corporate Event
View

Angiodynamics Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Angiodynamics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Angiodynamics backward and forwards among themselves. Angiodynamics' institutional investor refers to the entity that pools money to purchase Angiodynamics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K103 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K115 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K147 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K138 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K145 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.3 K125 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares5.4 K83 K
Note, although Angiodynamics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Angiodynamics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Angiodynamics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Angiodynamics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Angiodynamics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Stephen Trowbridge over a month ago via Macroaxis 
Purchase by Stephen Trowbridge of 1083 shares of Angiodynamics
James Clemmer over a month ago via Macroaxis 
Purchase by James Clemmer of 10000 shares of Angiodynamics
Helsel Dave over three months ago via Macroaxis 
Sale by Helsel Dave of 5000 shares of Angiodynamics
Stephen Trowbridge over three months ago via Macroaxis 
Exercise or conversion by Stephen Trowbridge of 14758 shares of Angiodynamics subject to Rule 16b-3
Dennis Meteny over three months ago via Macroaxis 
Exercise or conversion by Dennis Meteny of 6022 shares of Angiodynamics subject to Rule 16b-3
Stephen Trowbridge over three months ago via Macroaxis 
Exercise or conversion by Stephen Trowbridge of 4188 shares of Angiodynamics subject to Rule 16b-3
James Clemmer over three months ago via Macroaxis 
Exercise or conversion by James Clemmer of 25123 shares of Angiodynamics subject to Rule 16b-3
Stephen Trowbridge over three months ago via Macroaxis 
Payment of 1509 shares by Stephen Trowbridge of Angiodynamics subject to Rule 16b-3
Stephen Trowbridge over three months ago via Macroaxis 
Exercise or conversion by Stephen Trowbridge of 8357 shares of Angiodynamics subject to Rule 16b-3
Chad Campbell over three months ago via Macroaxis 
Exercise or conversion by Chad Campbell of 6195 shares of Angiodynamics subject to Rule 16b-3
James Clemmer over three months ago via Macroaxis 
Exercise or conversion by James Clemmer of 25123 shares of Angiodynamics subject to Rule 16b-3
Chad Campbell over three months ago via Macroaxis 
Exercise or conversion by Chad Campbell of 3104 shares of Angiodynamics subject to Rule 16b-3

Angiodynamics Investors Sentiment

The influence of Angiodynamics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Angiodynamics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Angiodynamics' public news can be used to forecast risks associated with investment in Angiodynamics. The trend in average sentiment can be used to explain how an investor holding Angiodynamics can time the market purely based on public headlines and social activities around Angiodynamics. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Angiodynamics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Angiodynamics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Angiodynamics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Angiodynamics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Angiodynamics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Angiodynamics' short interest history, or implied volatility extrapolated from Angiodynamics options trading.

Pair Trading with Angiodynamics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Angiodynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Angiodynamics will appreciate offsetting losses from the drop in the long position's value.

Moving against Angiodynamics

-0.72APAApa Corp Potential GrowthPairCorr
-0.56JPMJP Morgan Chase Fiscal Year End 13th of January 2023 PairCorr
-0.54GEOGeo Group Normal TradingPairCorr
-0.53PTENPatterson-Uti Energy Sell-off TrendPairCorr
The ability to find closely correlated positions to Angiodynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Angiodynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Angiodynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Angiodynamics to buy it.
The correlation of Angiodynamics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Angiodynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Angiodynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Angiodynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Trending Equities. Note that the Angiodynamics information on this page should be used as a complementary analysis to other Angiodynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Angiodynamics Stock analysis

When running Angiodynamics price analysis, check to measure Angiodynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Angiodynamics is operating at the current time. Most of Angiodynamics' value examination focuses on studying past and present price action to predict the probability of Angiodynamics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Angiodynamics' price. Additionally, you may evaluate how the addition of Angiodynamics to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Is Angiodynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Angiodynamics. If investors know Angiodynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Angiodynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
535.4 M
Quarterly Revenue Growth YOY
0.059
Return On Assets
(0.0274) 
Return On Equity
(0.08) 
The market value of Angiodynamics is measured differently than its book value, which is the value of Angiodynamics that is recorded on the company's balance sheet. Investors also form their own opinion of Angiodynamics' value that differs from its market value or its book value, called intrinsic value, which is Angiodynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Angiodynamics' market value can be influenced by many factors that don't directly affect Angiodynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Angiodynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine Angiodynamics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Angiodynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.